Neuroone Medical Technologies is trading 5.1% down at $2.04 after the August 20, 2026 regular session closed at $2.15, following a broader risk-off session.
- No new company-specific announcement was identified for August 20.
- The S&P 500 fell 0.75% and Nasdaq Composite declined 1.16%.
- Recent earnings showed 16% product-revenue growth, manufacturing constraints, and reduced fiscal-year revenue guidance.